Therapeutic compounds and their use in cancer
US7595401B2 · kind B2 · utility
11Cited by
0References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2007 |
| Grant date | Sep 29, 2009 |
| Priority date | — |
| Expiry date | May 14, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of Formula Iand their therapeutic uses, wherein substituent A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carboxylic group, B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group, R1 is chosen from hydro, alkyl, aryl, heteroaryl amino and halo, and L1 and L2 are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.